Symbiotec Pharmalab share price
NSE: SYMBIOTECBSE: 544889Pharmaceuticals & Biotechnology
Last close ₹1,164.20down ₹33.30 (2.78%)BSE ₹1,164.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,197.50.
Range of traded prices from listing on 1 Sep 2026 to 23 Oct 2026
₹934.20Low, 1 Sep 2026₹1,309.90High, 16 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹7,481 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No balance sheet
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Sep 2026
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,58,23231.5% delivered
Results
Consolidated; ₹ crore, the quarter to Jun 2026; no annual accounts on record yet.Quarterly results
Quarter to Jun 2026Filed 21 Sep
- Revenue
- ₹218 Cr
- Net profit
- ₹14 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 6.4%
Revenue by quarter
Net profit by quarter, a loss in red
Business segments
In the quarter to Jun 2026 the company reports one business segment, Manfucaturing of Pharmaceutical, which carries all its revenue.
Mutual funds holding it
35 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before.Mutual fund holdings
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 7
- AddedAdded. Funds that held more shares than at the end of the month before.
- 17
- CutCut. Funds that held fewer shares than at the end of the month before.
- 2
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 9
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end.
- 25
| Fund | |||
|---|---|---|---|
 Motilal Oswal Small Cap FundMotilal Oswal Mutual Fund | 9,29,089 | 1.32% | ₹109.3 Cr |
 ICICI Prudential Small Cap FundICICI Prudential Mutual Fund | 8,07,290 | 0.97% | ₹95.0 Cr |
 Mirae Asset Aggressive Hybrid FundMirae Asset Mutual Fund | 7,73,462 | 0.99% | ₹91.0 Cr |
| Mirae Asset Midcap FundMirae Asset Mutual Fund | 7,40,752 | 0.45% | ₹87.2 Cr |
| Mirae Asset Multicap FundMirae Asset Mutual Fund | 5,50,000 | 1.20% | ₹64.7 Cr |
| Mirae Asset ELSS Tax Saver FundMirae Asset Mutual Fund | 5,47,602 | 0.26% | ₹64.4 Cr |
| Mirae Asset Small Cap FundMirae Asset Mutual Fund | 4,94,818 | 1.00% | ₹58.2 Cr |
| Mirae Asset Healthcare FundMirae Asset Mutual Fund | 4,74,270 | 1.60% | ₹55.8 Cr |
 HDFC Pharma and Healthcare FundHDFC Mutual Fund | 4,04,865 | 1.36% | ₹47.6 Cr |
 Mahindra Manulife Small Cap FundMahindra Manulife Mutual Fund | 2,53,050 | 0.55% | ₹29.8 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Symbiotec Pharmalab in market cap.
Symbiotec Pharmalab is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Strides Pharma ScienceSTAR | 9,354 | 15.2 | 3.0 | 11.5 | +7.3% | – | 21.7% | 15.1% | 0.49% |
 Viyash ScientificVIYASH | 9,017 | – | 3.1 | 15.5 | +96.5% | – | – | 11.2% | 0.00% |
 Blue Jet HealthcareBLUEJET | 9,001 | 38.3 | – | – | −27.5% | −34.5% | 18.8% | 18.1% | 0.25% |
 Procter & Gamble HealthPGHL | 8,325 | 23.3 | 15.9 | 17.5 | – | – | 67.2% | 84.2% | 4.09% |
 Aarti PharmalabsAARTIPHARM | 7,443 | – | 3.5 | 19.0 | +1.2% | – | – | 11.2% | 0.43% |
 Sanofi Consumer Healthcare IndiaSANOFICONR | 7,388 | 27.8 | 21.2 | 19.5 | +31.2% | +33.0% | 87.9% | 97.6% | 2.34% |
 Morepen LaboratoriesMOREPENLAB | 6,769 | 48.2 | 5.4 | 37.5 | +9.5% | +51.8% | 11.7% | 10.3% | 0.16% |
 Bliss GVS PharmaBLISSGVS | 6,628 | 48.7 | 5.6 | 34.5 | +20.6% | +27.7% | 12.1% | 12.3% | 0.24% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
Sep 2026
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 1,197.50 | 1,197.50 | 1,153.50 | 1,164.20 | 1,170.38 | 2,58,232 | 31.5% |
| 22 Oct 2026 | 1,194.10 | 1,218.20 | 1,168.10 | 1,197.50 | 1,193.26 | 2,97,702 | 30.2% |
| 21 Oct 2026 | 1,240.00 | 1,246.50 | 1,187.00 | 1,208.40 | 1,208.04 | 4,31,881 | 40.1% |
| 19 Oct 2026 | 1,268.10 | 1,286.80 | 1,223.30 | 1,238.60 | 1,261.28 | 5,10,021 | 41.1% |
| 16 Oct 2026 | 1,253.00 | 1,309.90 | 1,235.00 | 1,279.50 | 1,280.16 | 10,06,476 | 39.6% |
| 15 Oct 2026 | 1,256.00 | 1,308.00 | 1,233.70 | 1,254.90 | 1,273.25 | 21,09,252 | 31.7% |
| 14 Oct 2026 | 1,175.00 | 1,284.50 | 1,170.10 | 1,253.20 | 1,242.91 | 24,73,759 | 32.3% |
| 13 Oct 2026 | 1,101.20 | 1,177.50 | 1,101.20 | 1,173.00 | 1,149.21 | 11,21,191 | 33.0% |
| 12 Oct 2026 | 1,092.60 | 1,116.90 | 1,067.60 | 1,101.20 | 1,097.86 | 4,46,964 | 29.8% |
| 9 Oct 2026 | 1,081.00 | 1,112.50 | 1,078.10 | 1,087.50 | 1,091.92 | 4,02,278 | 41.0% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Symbiotec Pharmalab Limited
- NSE symbol
- SYMBIOTEC
- BSE code
- 544889
- ISIN
- INE899I01028
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Sep 2026
- Face value
- ₹2
- CIN
- U24232MP2002PLC015293
- Corporate identity number, the registrar of companies' code for it